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Abstract
Microdialysis is a diffusion-based sampling method that can be useful for monitoring
various biological systems. Matrix metalloproteinases are a class of enzymes responsible for
remodeling the extracellular matrix that, when dysregulated, are linked to various diseases. The
delivery method of microdialysis is of particular interest as a sampling technique for enzymatic
reactions. Microdialysis was performed in vitro using a model enzyme, porcine pancreatic
elastase, because it is a useful substitute for matrix metalloproteinases. A colorimetric substrate
for elastase, succinyl-ala-ala-ala-p-nitroanilide, and its product p-nitroaniline were measured
using a UV-Vis spectrophotometer. Using an expanded Beer’s Law equation, both analytes’
concentrations were determined simultaneously from one dialysate sample using two of their
overlapping absorbance wavelengths. The experiment aimed to test the effect flow rate,
enzymatic solution concentration, and substrate concentration had upon the extraction efficiency
of the procedure. Flow rate manipulations were consistent with literature, with higher flow rates
yielding lower extraction efficiencies. Increasing the elastase concentration showed an increase
in extraction efficiency of the substrate, whereas increasing the substrate concentration had no
apparent effect on the extraction efficiency. Increasing either elastase or Succ-(Ala)3-p-NA
concentrations, however, yielded higher p-NA concentrations.
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I. Introduction:
I. i. Overview:
Extracellular matrix (ECM) remodeling by proteases called matrix metalloproteinases
(MMPs) is a critically important process that functions normally in embryogenesis or
homeostasis, but potentially can become dysregulated leading to various self-destructive disease
states. This class of 23 endopeptidases serves to remodel extracellular matrix proteins, such as
collagen and elastase, plays a role in embryonic development, and studies have linked
upregulated MMP concentrations to various disease states including arthritis, cancer and wound
healing.1, 2 Typically, many MMPs are activated simultaneously, thus monitoring the in vivo
activity would be of clinical significance in recognizing when a patient may be at risk of
dysregulated MMP activity.5 Current methods to monitor the activity of MMPs include
zymography, requiring extraction of whole tissue and a lengthy monitoring of both active and
inactive forms of the enzymes1, and immunochemical methods, though quantitative, cannot
distinguish between active and pro-enzyme forms of the proteins.4 Colorimetric assays are also
used, however are limited by the fluorescent tags available and require LC MS procedures to
distinguish. However, microdialysis sampling, used with judicious choices of substrates and an
appropriate mathematical model, may allow for accurate monitoring of in vivo MMP activity in
real time.
I. ii. Microdialysis Sampling
Microdialysis is a widely-used, minimally invasive, in vivo method to collect chemical
components in tissue.6 The process is performed using small probes with a 4-10 mm semipermeable membrane tip of a specific molecular weight cutoff (MWCO), allowing size selective
passage of molecules to diffuse in or out. A perfusion fluid, matching the sample solution’s ionic
5

strength and chemical moiety, is loaded into a syringe and pumped through the inner membrane
lumen at typical flow rates of 0.5-2.0 µL/min into a sample solution.6 Analytes can also diffuse
from the sample medium into the probe through a diffusion gradient as well. The target analytes,
following diffusion into the probe, and any remaining perfusate travel through the outlet, as
dialysate fluid, into a collection vial.7-10 This process is summarized in Figure 1.

Figure 1: Diagram depicting diffusion-based movement of analyte using a microdialysis probe.
Perfusate enters through the inlet and out of the inner tube where it can then interact with the semipermeable membrane either diffusing into the solution or continuing into the dialysate. Analyte from
the solution diffuses into the probe and is carried into the dialysate through the outlet tubing into a
3
collection vial.

Microdialysis as a sampling method holds several advantages to its usage. The size,
usually 200-500 µm in diameter and 1-30 mm in length, allows minimally invasive in vivo
sampling, with applications that began with studies in rat brain biochemistry to human studies of
various organ systems.6, 11 Another benefit comes from the semi-selectivity offered by the semipermeable membrane. Depending on the probe’s MWCO, a generic local sampling can be
performed which could allow macromolecular sampling of proteins or selective sampling of low
molecular weight compounds such as neurotransmitters or glucose. This provides a versatile
applicability of microdialysis that cements its place as a useful biological sampling device.
6

Since microdialysis is often a function of variables like membrane length, membrane
material, membrane MWCO, and diffusion coefficients, the extraction efficiency (EE) of
microdialysis is usually displayed as a percentage, using Equation 1, to provide quantification of
the probe’s sampling efficiency.4, 6 In this equation, Coutlet refers to the concentration of analyte
collected as dialysate, Cinlet refers to the concentration of analyte present in the perfusate, and
Csample refers to the far-field concentration of analyte outside of the probe.
EE =

!!"#$%# !!!"#$%
!!"#$%& !!!"#$%

× 100%

(1)

By manipulating these concentrations, the extraction efficiency equation can be further modified
into relative recovery (Equation 2), in which Cinlet is 0 and Csample is assumed a finite amount, or
delivery (Equation 3), in which Csample is set to 0 and Cinlet is a finite amount. Recovery is useful
for quantifying the effectiveness of microdialysis as a sampling tool for an unknown
concentration of analyte in solution, whereas delivery (also known as loss) is beneficial in
pharmacokinetic and activity assays of enzymes by introducing enzymatic substrate via the
perfusate fluid into an enzymatic solution.
!

Relative Recovery = EE!"# = ! !"#$%# × 100%
!"#$%&

Relative Delivery = EE!"## =

!!"#$%# !!!"#$%
!!!"#$%

× 100%

(2)

(3)

The delivery method of microdialysis is of interest because the coupling of size-selective
permeability of the probe and proper analysis techniques of dialysate can allow local monitoring
of in situ biological processes by instigating biochemical processes, such as an MMP reaction, by
delivery of substrate and analysis of the recovered products with increased temporal resolution.
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I. iii. Usage of an in vitro Enzymatic Model System
Sourcing MMPs is quite expensive, and as previously stated, they exist naturally as a mixture of
MMP subtypes in a zymogen form until activated.1, 4, 5 Because of this, it is difficult to perform controlled
cost-efficient in vivo studies regarding MMPs. For this study, and many others preceding it,1, 4, 5 porcine
pancreatic elastase (PPE) is used as a useful model enzyme since it has the same substrate specificity as
MMP-12, but at a fraction of the cost. Though all 23 MMPs are of clinical significance, MMP-12, or
macrophage elastase, is one of interest due to it implication in emphysemas, abdominal aortic aneurysms,
and atherosclerosis.2 This MMP cleaves extracellular matrix proteins such as elastin, collagen, and fibrins
normally, but can, when dysregulated, lead to the weakening of vital cardio-respiratory tissues due to this
unregulated cleaving mechanism. Therefore despite PPE being used as preliminary model for one MMP,
the MMP in question still has clinical relevance in developing a suitable sampling method.
PPE cleaves a colorimetric substrate, succinyl-trialanine-p-nitroanilide (Succ-(Ala)3-p-NA), into
the product p-nitroaniline (p-NA) and has been previously described for microdialysis studies by the
Stenken group (Figure 2).6 Due to the colorimetric metabolic product, UV-Vis spectrophotometry can be
then used to quantify the recovered product and the EE of the delivered substrate as a method of
quantifying the activity surrounding a microdialysis probe of a serine protease, elastase.

Figure 2: Diagram depicting a microdialysis probe in "Delivery" mode. The substrate (Succ-(Ala)3-pNA) is perfused through the probe so as to diffuse into a solution of elastase. The metabolic product
4
(p-NA) is then diffused back into the probe as dialysate.
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I. iv. UV-Vis Spectrophotometry
Initially microdialysis was limited in its utility due to detection limitations requiring 50100 µL samples to gain any appreciable readings of dialysate.6 However, with current advances
in analysis methods, this no longer acts as major impedance for microdialysis studies. A
commonly used method to determine solution concentrations is spectrophotometry. Using Beer’s
Law (Equation 4), the absorbance of a chemical is directly proportional to the chemical’s
concentration, [X], its molar absorptivity, ε! , and the path length, b (usually in values of 1 so as
to be negligible).12
A = ε! b[X]

(4)

Thus, Beer’s Law allows the use of spectrophotometry to quantify dilute solutions such as the
dialysate of a microdialysis sampling procedure. Thermo-Fischer’s NanoDrop 2000c model is
particularly useful in this regard as it can reliably measure the absorbance of aliquots as small as
1-2 µL in volume, a convenient amount since microdialysis collects at 0.5 to 2 µL/min rates
normally. The low aliquot size for the NanoDrop eliminates one of the largest burdens with
microdialysis, that being the time necessary to accumulate enough dialysate to make analytical
measurements.
Substances have a maximum absorbance wavelength (λmax) where the largest light
absorbance occurs, however they can and will still absorb over a range of nearby wavelengths as
well. In this experiment, a colorimetric substrate, Succ-(Ala)3-p-NA, is cleaved into p-NA,
however their maximum absorbance wavelengths overlap, and since they both will be present in
the dialysate, the measurements at their respective maxima will not be sufficient to quantify their
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concentrations as each chemical will contribute at each wavelength. This is because absorbance
is an additive quantity, as expressed by equation 5.12
A! = ε!! b X + ε!! b Y
!!
A!! = ε!!
! b X + ε! b Y

(5)

In the above equations, A! refers to the total absorbance read by a spectrophotometer at one
wavelength, a value made up of the Beer’s law calculated absorbance for two separate chemicals,
X and Y. Their combined absorbance makes up the absorbance measured by the
spectrophotometer. A!! refers to the total absorbance at another wavelength. Each of these
equations use different molar absorptivities specific to the chemical at that specific wavelength
the spectrophotometer is measuring. Thus standards of each chemical can be produced to
develop a calibration curve at both absorbance maximum wavelengths to determine their molar
absorptivity. Since each quantity but the concentrations are known, a system of equations is
possible using equation 6.12

X =

!!

!!! !

!!!

!!!
!!

!!! !
!!!
!!

[Y] =

!!! !

!!!
!!

!!! ! !!
!!
!!!
!! !
!!! ! !!! !
!!
!!!
! ! !! !

The concentrations of p-NA and Succ-(Ala)3-p-NA in the dialysate can thus be individually
calculated in this method by solving the determinants present in the above equation after
measuring the absorbance at both wavelength maxima.
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(6)

II. Materials and Methods
II. i. Chemicals and Equipment
The enzyme, elastase from porcine pancreas (E1250), its substrate, N-succinyl-L-AlaAla-Ala -p-nitroanilide (S4760), and its colorimetric product, 4-nitroaniline (N2128) were
purchased from Sigma Aldrich (St. Louis, MO). A 2 mM stock of Succ-(Ala)3-p-NA in 10 mM
PBS (pH=7.4) was produced from the Sigma solid; daily substrate solutions were diluted from
this 2 mM solution for experimentation. Enzyme solutions were produced daily from the Sigma
stock solution into a 10 mM PBS buffer (pH=7.4). For microdialysis, CMA/20 probes (MWCO
20 kDa) were purchased from Harvard Apparatus (Holliston, MA). The pumps (MD-1000),
drivers (MD-1001), and 1 mL syringes (MDN-0100) used for microdialysis were purchased from
BASi (West Lafayette, IN). Spectrophotometric analysis of the solutions was performed using a
NanoDrop 2000c purchased from Thermo Fisher (Pittsburgh, PA).
II. ii. Formation of Calibration Curves for Substrate and Product
A 2 mM Succ-(Ala)3-p-NA stock solution in 10 mM phosphate buffered saline at 7.4 pH
was produced, from which a 1000 µM standard was pulled to determine the maximum
absorbance wavelength of Succ-(Ala)3-p-NA. Standards were also created for p-NA in this same
manner. PBS was used to obtain the blank for the NanoDrop, and full UV-Vis absorbance scans
were collected to determine the maximum absorbance wavelengths for Succ-(Ala)3-p-NA and pNA. From this reading, the largest absorbance peaks were selected for both chemicals,
correlating to 315 nm for Succ-(Ala)3-p-NA and 380 nm for p-NA. However, it was noted that
the absorbance curves overlapped slightly for both chemicals at these wavelengths.
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To produce calibration curves for the NanoDrop, the 1000 µM solutions were serially
diluted to 500, 250, 125, 62.5, 31.25, and 15.625 µM solutions. These solutions were then
analyzed within the NanoDrop in triplicate 2 µL aliquots at both 315 and 380 nm absorbance
readings. This data was averaged and fitted with a linear trend in Excel to provide a calibration
curve at each wavelength for both Succ-(Ala)3-p-NA and p-NA. Beer’s Law at a path length of 1
mm was used to determine the molar absorptivity of Succ-(Ala)3-p-NA and p-NA at both 315
and 380 nm wavelengths using these calibration curves.
II. iii. Microdialysis Sampling
Microdialysis sampling experiments were performed several times while adjusting
variables such as pump flow rate, enzyme concentration, and substrate concentration. The
sampling technique used three CMA/20 probes (each having a 20 kDa MWCO) submerged in
three 2 mL solutions of enzyme so as to fully cover the semi-permeable membrane of the probes.
A pump delivered Succ-(Ala)3-p-NA through the membrane inner lumen into the enzyme
solution as perfusate allowing collection of p-NA and unreacted Succ-(Ala)3-p-NA as dialysate.
The pump perfused Succ-(Ala)3-p-NA, loaded into three syringes, through the attached probes
for a set amount of time so as to collect approximately 10 µL of dialysate. The probes were
flushed with HPLC grade water for 15 minutes before and after any procedure at 3 µL/min.

Figure 3: Microdialysis setup used in these experiments. Three syringes, loaded with Succ-(Ala)3-p-NA
solutions, connect to three separate probes submerged in elastase solutions. The outlets empty into
separate microcentrifuge vials.
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The first experiment tested the fluid delivery of HPLC water from the pump and syringes
using FEP tubing into collection vials to ensure calibration of the equipment. The pump was set
to 3 µL/min perfusion, and fluid was collected for 5 minutes. Using gravimetric analysis, the
volume of the delivered fluid was determined and compared to the pump’s flow rate setting. This
was repeated again with the probes attached to the syringes in place of the FEP tubing. Results
were consistent with the pump’s flow rate settings (data not reported).
Next, delivery of 1000 µM Succ-(Ala)3-p-NA into 2 mL PBS buffer solutions were
performed at 1.5, 1.0, and 0.8 µL/min flow rates at 7, 10, and 12.5 min intervals, respectively.
For this experiment nine buffer solutions were made so that fresh solutions were used for each
flow rate for each probe. The probes were allowed to equilibrate at the desired flow rate for 15
minutes prior to dialysate collection so as to flush the probes of previous analyte concentrations.
Dialysate was collected into empty 1.5 mL microcentrifuge vials for each probe at each flow
rate.
The remaining experiments adjusted either enzyme concentration or substrate
concentration using the same procedure as outlined above for the flow rate manipulations with
minor variations. In the enzyme manipulation experiment, 1000 µM Succ-(Ala)3-p-NA was
perfused at 1.5 µL/min into three sets of three 2 mL elastase solutions at 2.0, 1.0, and 0.5
unit/mL elastase concentrations, made by serial dilution from the Sigma stock, for 7 minutes.
The substrate manipulation experiment perfused 1000, 500, and 250 µM Succ-(Ala)3-p-NA
solutions perfused at 1.5 µL/min into three sets of three 2 mL elastase solutions at 1.0 unit/mL
elastase concentration. In each of these experiments the same equilibration method was used.
Both experiments were performed at room (21° C) and physiological (37° C) temperature.
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II. iv. Dialysate Concentration Determination Using NanoDrop Spectrophotometry
The dialysate collected from each of the above outlined procedures held enough fluid for
triplicate 2 µL aliquot readings with some excess if necessary. Each aliquot was measured at 315
and 380 nm absorbance. These readings were averaged between the three probes and used for the
following calculations. A system of Beer’s Law equations produced from the calibration curves
was used to determine the concentration of Succ-(Ala)3-p-NA and p-NA present in the dialysate.
The concentration of the Succ-(Ala)3-p-NA concentrations loaded into each syringe were also
collected and measured using the NanoDrop in the same manner. The perfusate and dialysate
concentrations were then compared to determine EEloss of substrate.

III. Results and Discussion
III. i. Absorbance Spectra and Calibration Curves for Analytes
Prior to further experimentation it was necessary to determine the absorbance
characteristics of the two analytes being measured in these experiments, Succ-(Ala)3-p-NA and
p-NA. From the prepared 1000 µM samples of either analyte, absorbance spectra were measured
using the NanoDrop spectrophotometer for both Succ-(Ala)3-p-NA and p-NA. These spectra are
both displayed overlaid in Figure 4. As can be seen in the diagram, both analytes’ maximum
absorbance wavelengths partially overlap requiring the expanded Beer’s Law equation discussed
earlier (Equation 5). Using the maximum wavelengths, 315 nm for Succ-(Ala)3-p-NA and 380
nm for p-NA, together provides a larger signal for measurement for both analytes, and also offers
a method to determine the concentrations of two analytes simultaneously from one dialysate
sample.
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Figure 4: Absorbance spectra measured for 1000 μM Succ-(Ala)3-p-NA and 1000 μM p-NA. The maxima are labeled as
well as the corresponding measurement on the non-dominant spectra showing the overlap of the absorbance
measurements due to the combination of unreacted Succ-(Ala)3-p-NA substrate and p-NA product that would be
present in microdialysis dialysate.

After determination of the absorbance spectra, the 1000 µM samples of Succ-(Ala)3-pNA and p-NA were serially diluted to form a series of standards from which calibration curves
were constructed using the absorbance measurements at both 315 and 380 nm for both analytes.
These curves are expressed as Figures 5 and 6 for Succ-(Ala)3-p-NA and p-NA respectively. The
slopes of these curves represent the molar absorptivity, ε, times the path length as shown by
Beer’s Law. Since the path length is 1 mm for the NanoDrop 2000c, the slopes of the curves
were used as the molar absorptivities corresponding to 315 and 380 nm for both Succ-(Ala)3-pNA and p-NA that were used for future experiments. These values are displayed in Table 1 and
match relatively consistently to previously reported values from the Stenken Lab.13
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Figure 5: Calibration curve formed from 1000, 500, 250, 125, 62.5, 31.25, and 15.625 μM standards of Succ-(Ala)3-pNA in 10 mM PBS (pH=7.4). Data points represented as averaged absorbance measurements at 315 and 380 nm using
a NanoDrop 2000c (n=3).

Figure 6: Calibration curve formed from 1000, 500, 250, 125, 62.5, 31.25, and 15.625 μM standards of p-NA in 10 mM
PBS (pH=7.4). Data points represented as mean absorbance measurements at 315 and 380 nm using a NanoDrop
2000c (n=3).
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Table 1: Molar absorptivities for Succ-(Ala)3-p-NA and p-NA at both 315 and 380 nm derived from calibration curves to be used
in Beer’s Law calculations to determine dialysate analyte concentrations of either molecule. The molar absorptivities are
labeled in the form εX,Y Where X specifies the analyte, S for Succ-(Ala)3-p-NA and P for p-NA, and Y specifies the wavelength the
absorptivity corresponds.

As can be seen from the calibration curves, there is a slight, but apparent, overlap in
absorbance contributions from either analyte at the respective wavelengths. It is because of this
that the four molar absorptivities displayed in Table 1 will need to be used in conjunction with
Beer’s Law and the matrix equation shown before (Equation 6) to determine the combined
dialysate concentrations of each analyte.
III. ii. Microdialysis Flow Rate Manipulation Results
After the calibration curves were developed, microdialysis experiments were performed
to test the effect on EEloss (Delivery) and product formation under various conditions. The first
experiment tested the effect flow rate had upon EEloss by eluting 1000 µM Succ-(Ala)3-p-NA
through three probes to be delivered into triplicate 2 mL sample of 10 mM PBS buffer without
enzyme present. The dialysate absorbance measurements were then used to determine the Succ(Ala)3-p-NA concentration remaining in dialysate. Since no enzyme was present, no p-NA was
present in the dialysate and a simplified Beer’s Law equation using only the 315 nm molar
absorptivity was used to calculate the concentration. The results of this experiment are presented
in Figure 7. The results of this experiment show a decrease in extraction efficiency for
microdialysis as flow rate increases. This trend is well established in the literature4, 6 occurring
due to a lower residency time for analytes to successfully diffuse through the semi-permeable
membrane. Since the flow rates used in this experiment are relatively close together in
17

magnitude the decrease appears linear. However, were the flow rate manipulations increased
upwards of 5 µL/min a more exponential decrease would likely occur. This experiment was only
performed at room temperature (21° C), however had it been a higher temperature the extraction
efficiency would likely be systematically raised at each flow rate due to temperature having a
proportionate role in determination of diffusion coefficients. Data was not collected to test this
hypothesis for this experiment, however.

Figure 7: Flow rate vs EEloss of a microdialysis-based delivery of 1000 μM Succ-(Ala)3-p-NA eluted at 0.8, 1.0, and 1.5
μL/min flow rates for 12.5, 10, and 7 min respectively into a 2 mL solution of 10 mM PBS (pH=7.4) at 21° C . There was
no Elastase enzyme present in the samples. Data represented as mean ± SD.

Though the 1.5 µL/min yielded the lowest EEloss of the three flow rates tested, it was used for all
subsequent experiments since it yielded quantifiable concentrations of Succ-(Ala)3-p-NA and
would only need to elute for approximately 7 minutes to provide enough dialysate for triplicate
measurements using the NanoDrop spectrophotometer.
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III. iii. Microdialysis Enzyme Concentration Manipulation Results
While EEloss can be directly manipulated through judicious choice of flow rate, this
experiment aimed to note the effect that manipulating the concentration of the enzymatic
solution itself had on EEloss for the microdialysis delivery. To do this, the concentration of
elastase enzyme present in the solution was adjusted through serial dilution to produce triplicate
0.5, 1.0, and 2.0 unit/mL elastase solutions in 2 mL centrifuge vials. Following the elution of
1000 µM Succ-(Ala)3-p-NA into these solutions for 15 minutes of equilibration and 7 minutes of
collection, the dialysate was analyzed using the NanoDrop spectrophotometer at 315 and 380
nm. The results of this experiment are displayed in Table 2 as well as Figures 8 and 9.
Table 2: Results of eluting 1000 μM Succ-(Ala)3-p-NA into increasing concentrations of elastase solution. Data for 21° C and
37° C experiments are shown. Elution allowed to equilibrate for 15 min and collect for 7 min at 1.5 μL/min. Data represented as
mean ± SD (n=3)

The results of this experiment show that the concentration of the enzyme present in the sampled
solution has an apparent effect on the EEloss of the microdialysis technique. There is an
observable positive trend correlated with the extraction efficiency as the sample’s elastase
concentration increases. What this implies is a stronger delivery of Succ-(Ala)3-p-NA into the
solution from the microdialysis probe while also producing a stronger p-NA yield due to an
increase in delivered Succ-(Ala)3-p-NA to react. The product recovery increase is likely further
explained due to an increased amount of available elastase active sites to facilitate the reaction.

19

Figure 8: Elastase sample concentration vs. EEloss of microdialysis delivery of 1000 μM Succ-(Ala)3-p-NA into triplicate 2
mL elastase solutions (pH=7.4) at 0.5, 1.0, and 2.0 units/mL. Solutions allowed to equilibrate for 15 mins prior to a 7
min collection at 1.5 μL/min flow rate. Data represented as mean ± SD (n=3).

Figure 9: Elastase concentration vs. product (p-NA) collected in dialysate following delivery of 1000 μM Succ-(Ala)3-pNA into triplicate 2 mL elastase solutions (pH=7.4) at 0.5, 1.0, and 2.0 units/mL. Solutions allowed to equilibrate for 15
minutes prior to a 7 min collection at 1.5 μL/min flow rate. Data represented as mean ± SD (n=3).
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This increased EEloss is likely explained by concentration gradients. In the event of an
increased enzyme concentration, more active sites remain available to collect the substrate, Succ(Ala)3-p-NA. This reduces the apparent concentration of substrate in the solution as compared to
a lower concentrated enzymatic solution since more substrate is bound as an enzyme-substrate
complex. Thus this further facilitates the diffusion of Succ-(Ala)3-p-NA into the solution since
the concentration of the Succ-(Ala)3-p-NA in the solution is reduced faster in the same amount of
time due to the presence of more enzyme. This in turn, on the other hand, increases the apparent
concentration of p-NA in solution following the reaction since more substrate can react in the
same amount of time, further facilitating the diffusion of p-NA into the probe for recovery down
its now increased concentration gradient. This trend is more apparent in Table 2 by comparing
the ratio of recovered p-NA to the lost Succ-(Ala)3-p-NA. As the concentration of the elastase
sample increased so did this ratio. This implies that the rate at which the p-NA is recovered is
slightly higher than the rate at which the Succ-(Ala)3-p-NA is being delivered, otherwise the
ratio would decrease as the elastase concentration increased. These experiments were performed
at room temperature (21° C) and physiological (37° C), and at the higher temperature the data
appears to show the same trend, however systematically shifted upward likely due to the
increased activity of the elastase enzyme at its preferred temperature condition. The results of
this experiment could prove to be useful information since a noticeable trend can be seen to be
associated with the EEloss of a microdialysis delivery into solutions of increased enzymatic
concentrations. Normally EEloss is varied by flow rate manipulations by researchers, but the data
appears to suggest the properties of the sample itself can also impact the delivery.
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III. iv. Microdialysis Substrate Concentration Manipulation Results
The next experiment tested the effect manipulation of the Succ-(Ala)3-p-NA
concentration in the perfusate had upon EEloss and p-NA recovery. In this experiment, serially
diluted concentrations of 250, 500, and 1000 µM Succ-(Ala)3-p-NA were delivered into three
sets of triplicate 2 mL 1.0 unit/mL solutions of elastase. As before, each concentration of Succ(Ala)3-p-NA was eluted for 15 minutes of equilibration and 7 minutes of collection, the dialysate
of which was analyzed at 315 and 380 nm absorbance wavelengths to determine the
concentration of p-NA and unreacted Succ-(Ala)3-p-NA. The results of these experiments are
displayed in Table 3 and Figures 10 and 11.
Table 3: Results of eluting 250, 500, and 1000 μM Succ-(Ala)3-p-NA into 1.0 unit/mL elastase solutions. (Note: the
concentrations listed in the table reflect the concentration of syringe perfusate measured through UV-Vis spectrophotometry
following each elution) Data for 21° C and 37° C experiments are shown. Elution allowed to equilibrate for 15 min and collect
for 7 min at 1.5 μL/min. Data represented as mean ± SD (n=3)

The results of this experiment show a slightly different trend than when the elastase
concentration was manipulated. From the data presented in Figure 10, it appears that increasing
the substrate concentration does not have a significant effect on the EEloss of the microdialysis
delivery method. At each concentration the EEloss remains relatively constant at approximately
38% for room temperature (21° C) and approximately 56% for physiological (37° C). However,
it does seem that the physiological 1000 µM EEloss breaks this trend slightly. This may be due to
difficulty observed in the lab at maintaining the sand bath used for the experiment at 37° C.
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Figure 10: Succ-(Ala)3-p-NA concentration vs. EEloss of microdialysis delivery of various concentrations of Succ-(Ala)3-pNA into triplicate 2 mL elastase solutions (pH=7.4) at 1.0 unit/mL. Solutions allowed to equilibrate for 15 mins prior to
a 7 min collection at 1.5 μL/min flow rate. Data represented as mean ± SD (n=3).

Figure 11: Succ-(Ala)3-p-NA concentration vs. product (p-NA) collected in dialysate following delivery of various
concentrations of Succ-(Ala)3-p-NA into triplicate 2 mL elastase solutions (pH=7.4) at 1.0 unit/mL. Solutions allowed to
equilibrate for 15 minutes prior to a 7 min collection at 1.5 μL/min flow rate. Data represented as mean ± SD (n=3).
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Regardless, manipulating the substrate appears to have little to no effect on the EEloss of
the delivery. This is likely occurring because the enzyme concentration is not changing. It
remains at 1.0 unit/mL and thus becomes saturated with Succ-(Ala)3-p-NA faster reducing the
enhanced diffusion that was suspected in the previous experiment. Without this increased
diffusion, the delivery thus becomes flow rate dependent likely resulting in the constancy of the
EEloss. The increased temperature does appear to raise the EEloss systematically by a much higher
degree than in the previous experiment however. This could also be due to the inconsistent
temperature readings observed in the lab, but it may also be due to a combined effect the
temperature has upon the process. The increased temperature will raise the activity of the
elastase allowing it to facilitate the biochemical reaction faster in the same amount of time,
encouraging the trend seen in the previous experiment, but also the increased temperature will
proportionally increase the diffusion coefficients according to Fick’s Law. However, this doesn’t
explain why the same magnitude of increase was not experienced in the previous experiment.
Further replications of this experiment are likely necessary to gain a better understanding of this
phenomenon. Similarly to the previous experiment, the p-NA concentration increases with Succ(Ala)3-p-NA concentration since higher amounts of substrate are able to diffuse into the solution
if the perfusate is at a higher concentration. The steep slope experienced at the physiological
temperature suggests that this reaction is substrate limited and has not yet approached MichaelisMenten equilibrium. However, the lower temperature appears to have begun to plateau
suggesting an enzyme limitation. While an increase in the EEloss was not observed, a much larger
magnitude of recovered product was achieved between substrate concentrations. This could be
useful in artificially boosting the analyte signal for measuring the activity of an enzyme in
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question by encouraging a stronger product output by increasing the substrate eluted to facilitate
the reaction.

IV. Conclusion
Microdialysis could prove to be both a viable and useful method for instigating
biochemical reactions in vitro. The experiments reinforced literature observations linking
increased flow rates to decreased extraction efficiencies, further extablishing the need to use low
flow rates to achieve the highest resolution of results. The results of the experiments further
suggested that the extraction efficiency of the microdialysis delivery method is linked to the
activity of the enzyme in the solution, increasing the effectiveness of the delivery itself and the
output of product. This conclusion appears further supported by the absence of this trend when
adjusting the Succ-(Ala)3-p-NA concentrations instead. Some problems arose when trying to
raise the temperature of the solutions to physiological ranges due to observed uneven heating that
could have potentially skewed several of the results in this paper. To correct this, further
replicative experiments should be performed to determine if these were out of character results.
This could potentially be translated towards monitoring in vivo systems as a means of sampling
enzymatic processes. However, much more work will be necessary to account for increased
variables of a biological system as well as a means to model this behavior neatly for intuitive
use.
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